Ropes Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $5.11M | Sell |
34,266
-4,191
| -11% | -$615K | 0.99% | 24 |
|
|
2023
Q2 | $5.18M | Buy |
38,457
+722
| +2% | +$106K | 0.86% | 29 |
|
|
2023
Q1 | $6.01M | Buy |
37,735
+31
| +0.1% | +$4.74K | 1.09% | 22 |
|
|
2022
Q4 | $6.09M | Buy |
37,704
+1,055
| +3% | +$162K | 1.1% | 20 |
|
|
2022
Q3 | $4.92M | Buy |
36,649
+3,669
| +11% | +$526K | 1.03% | 23 |
|
|
2022
Q2 | $5.05M | Sell |
32,980
-118
| -0.4% | -$18K | 1.04% | 23 |
|
|
2022
Q1 | $5.37M | Sell |
33,098
-888
| -3% | -$129K | 0.92% | 23 |
|
|
2021
Q4 | $4.6M | Sell |
33,986
-10,057
| -23% | -$1.19M | 0.81% | 33 |
|
|
2021
Q3 | $4.75M | Buy |
44,043
+297
| +0.7% | +$33.9K | 0.76% | 33 |
|
|
2021
Q2 | $4.93M | Sell |
43,746
-475
| -1% | -$53.5K | 0.78% | 32 |
|
|
2021
Q1 | $5.08M | Buy |
44,221
+4,293
| +11% | +$459K | 0.89% | 25 |
|
|
2020
Q4 | $4.28M | Sell |
39,928
-1,985
| -5% | -$191K | 0.66% | 29 |
|
|
2020
Q3 | $3.67M | Sell |
41,913
-2,352
| -5% | -$221K | 0.71% | 28 |
|
|
2020
Q2 | $4.35M | Buy |
44,265
+1,787
| +4% | +$157K | 0.89% | 23 |
|
|
2020
Q1 | $3.24M | Buy |
42,478
+974
| +2% | +$83K | 0.82% | 28 |
|
|
2019
Q4 | $3.67M | Sell |
41,504
-5,265
| -11% | -$437K | 0.79% | 30 |
|
|
2019
Q3 | $3.54M | Buy |
46,769
+4,566
| +11% | +$313K | 0.75% | 30 |
|
|
2019
Q2 | $3.07M | Sell |
42,203
-765
| -2% | -$60.1K | 0.65% | 35 |
|
|
2019
Q1 | $3.46M | Sell |
42,968
-2,480
| -5% | -$203K | 0.92% | 29 |
|
|
2018
Q4 | $4.19M | Buy |
45,448
+5
| +0% | +$440 | 1.21% | 24 |
|
|
2018
Q3 | $4.3M | Buy |
45,443
+5,580
| +14% | +$529K | 1.06% | 25 |
|
|
2018
Q2 | $3.69M | Buy |
39,863
+98
| +0.2% | +$9.57K | 1% | 24 |
|
|
2018
Q1 | $3.76M | Buy |
39,765
+4
| +0% | +$439 | 1.03% | 25 |
|
|
2017
Q4 | $3.85M | Buy |
39,761
+3,495
| +10% | +$329K | 1.01% | 24 |
|
|
2017
Q3 | $3.22M | Sell |
36,266
-125
| -0.3% | -$9.52K | 0.87% | 27 |
|
|
2017
Q2 | $2.64M | Buy |
36,391
+116
| +0.3% | +$7.8K | 0.75% | 34 |
|
|
2017
Q1 | $2.36M | Buy |
36,275
+1,777
| +5% | +$112K | 0.68% | 39 |
|
|
2016
Q4 | $2.16M | Buy |
34,498
+847
| +3% | +$51.7K | 0.68% | 39 |
|
|
2016
Q3 | $2.12M | Sell |
33,651
-168
| -0.5% | -$10.9K | 0.72% | 37 |
|
|
2016
Q2 | $2.09M | Buy |
33,819
+1,162
| +4% | +$70.8K | 0.73% | 37 |
|
|
2016
Q1 | $1.86M | Sell |
32,657
-1,568
| -5% | -$87.4K | 0.82% | 32 |
|
|
2015
Q4 | $2.03M | Buy |
34,225
+6
| +0% | +$346 | 0.89% | 29 |
|
|
2015
Q3 | $1.86M | Buy |
34,219
+5,532
| +19% | +$360K | 0.98% | 25 |
|
|
2015
Q2 | $1.93M | Sell |
28,687
-3,035
| -10% | -$198K | 1.05% | 25 |
|
|
2015
Q1 | $1.86M | Buy |
+31,722
| New | +$1.92M | 0.96% | 26 |
|
Other funds holding ABBV
Ropes Wealth Advisors's ABBV Position: Q3 2023 in Review
Ropes Wealth Advisors reduced its AbbVie (ABBV) stake by 11% in Q3 2023, selling an estimated $615K and leaving 34,266 shares worth $5.11M. The position accounts for 0.99% of the portfolio, ranked #24.
Ropes Wealth Advisors first reported a position in ABBV in Q1 2015 and has held it in 35 quarters since. The position peaked at $6.09M in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.
- Ropes Wealth Advisors held 34,266 shares of AbbVie worth $5.11M as of Q3 2023.
- Ropes Wealth Advisors sold 4,191 AbbVie shares in Q3 2023, an estimated $615K.
- AbbVie made up 0.99% of Ropes Wealth Advisors's portfolio in Q3 2023, its #24 holding.
- Ropes Wealth Advisors first reported a position in AbbVie in Q1 2015 and has held it in 35 quarters since.
- Ropes Wealth Advisors's AbbVie position peaked at $6.09M in Q4 2022.
- 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.
Based on Ropes Wealth Advisors's 13F filing for Q3 2023, filed 19 Oct 2023.